Pharmacological Actions of LIVACT®

Mechanism of promotion of BCAA albumin synthesis

BCAA has been shown to have a pharmacological action to proactively activate the albumin synthesis signal and to increase albumin synthesis, and it is considered to be a mechanism to improve hypoalbuminemia.

Graph titled 'BCAA concentration-dependent promotion of albumin synthesis (in vitro)' showing the relationship between BCAA concentration (0–2 mM) and albumin production (ng/dish). Pink circles with error bars represent data points; a blue trend line indicates increased albumin synthesis with higher BCAA levels. Statistical significance is noted (p<0.05 vs 0 mM, Dunnett’s test). Hepatocytes from Wistar rats were cultured for 6 hours in media containing 0–2 mM BCAA. Data shown as Mean ± S.E.
Bar graph comparing albumin production (ng/dish) under three conditions: control, leucine, and leucine with mTOR inhibitor (rapamycin). Leucine significantly increases albumin production via mTOR activation, while rapamycin suppresses this effect. Hepatocytes from 6-week-old Wistar rats were cultured for 6 hours in media without amino acids, with 2mM leucine, or with 2mM leucine and 25mg/m² rapamycin. The study demonstrates leucine’s role in promoting albumin synthesis in vitro.

You are now leaving the EA Pharma website.

Thank you for browsing the EA Pharma website.
You are about to visit an external website.
(A new browsing window will be opened)

Click here to proceed

The Section is for Medical Professionals.

Terms of Use

The purpose of the section is to provide useful information to medical professionals (doctors, dentists, pharmacists, nurses, nutritionists, care workers, etc.) working in medical institutions.
Please note that the section is not intended to provide information to medical professionals outside of the approved countries, nor to the general public.

Doctor, Nurse, Pharmacist, Other Medical Professionals

If you are not a medical professional